Company / Shareholders' Equity
KIORA PHARMACEUTICALS INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$25.8M
FY2025
5-year range
$6.1M / $25.8M
FY2021-FY2025
Trend
+321.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +322% YoY in FY2025, a notable deviation from the 7-year average annual change of +52%.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of +31.2%.
Improved from $7M to $26M over the past 4 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +31.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +31.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 321.6% year-over-year.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.8M | +321.6% |
| FY2024 | $6.1M | -7.7% |
| FY2021 | $6.6M | +0.0% |
| FY2020 | $6.6M | -25.9% |
| FY2019 | $8.9M | +563.8% |
| FY2018 | -$1.9M | +0.0% |
| FY2017 | -$1.9M | -484.9% |
| FY2016 | -$329.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026